Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Successful implementation of the randomized discontinuation trial design: an application to the study of the putative antiangiogenic agent carboxyaminoimidazole in renal cell carcinoma--CALGB 69901.

Stadler WM, Rosner G, Small E, Hollis D, Rini B, Zaentz SD, Mahoney J, Ratain MJ.

J Clin Oncol. 2005 Jun 1;23(16):3726-32. Erratum in: J Clin Oncol. 2005 Jul 20;23(21):4808. Ratain, Mark J [added].

PMID:
15923569
2.

Sorafenib for the treatment of advanced renal cell carcinoma.

Kane RC, Farrell AT, Saber H, Tang S, Williams G, Jee JM, Liang C, Booth B, Chidambaram N, Morse D, Sridhara R, Garvey P, Justice R, Pazdur R.

Clin Cancer Res. 2006 Dec 15;12(24):7271-8. Review.

3.

Practice and progress in kidney cancer: methodology for novel drug development.

Rini BI, Weinberg V, Small EJ.

J Urol. 2004 Jun;171(6 Pt 1):2115-21. Review.

PMID:
15126769
4.

Angiogenesis and angiogenic inhibitors in renal cell carcinoma.

Sawhney R, Kabbinavar F.

Curr Urol Rep. 2008 Jan;9(1):26-33. Review.

PMID:
18366971
5.

Sorafenib: in advanced renal cancer.

McKeage K, Wagstaff AJ.

Drugs. 2007;67(3):475-83; discussion 484-5. Review.

PMID:
17335301
6.

EORTC-GU group expert opinion on metastatic renal cell cancer.

de Reijke TM, Bellmunt J, van Poppel H, Marreaud S, Aapro M.

Eur J Cancer. 2009 Mar;45(5):765-73. doi: 10.1016/j.ejca.2008.12.010. Epub 2009 Jan 20. Review.

PMID:
19157861
7.

Vaccine therapy in patients with renal cell carcinoma.

Van Poppel H, Joniau S, Van Gool SW.

Eur Urol. 2009 Jun;55(6):1333-42. doi: 10.1016/j.eururo.2009.01.043. Epub 2009 Jan 30. Review.

PMID:
19201522
8.

Metastatic renal cell carcinoma management.

Heldwein FL, Escudier B, Smyth G, Souto CA, Vallancien G.

Int Braz J Urol. 2009 May-Jun;35(3):256-70. Review.

9.

Other paradigms: randomized discontinuation trial design.

Stadler W.

Cancer J. 2009 Sep-Oct;15(5):431-4. doi: 10.1097/PPO.0b013e3181bd0431. Review.

PMID:
19826364

Supplemental Content

Support Center